Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 5, Number 1, January 1994   [Index by Author] 
Other Issues: Previous Next  

Down In this issue
Down Contents of the next issue
Down News
Down Editorials
Down Special articles
Down Commentary
Down Arena
Down Original articles
Down Book reviews
Down Clinical case
Down Short reports
Down Letters
Down Advertisements in this issue
Down Instructions to Authors


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

In this issue Back

In this issue
Ann Oncol 1994 5: 1. [PDF] [Request Permissions]  

Contents of the next issue Back

Contents of the next issue
Ann Oncol 1994 5: 1. [PDF] [Request Permissions]  

News Back

Waiting time for cancer patients in the U.K.: Not a problem in medical oncology
Ann Oncol 1994 5: 2. [PDF] [Request Permissions]  

EO9 to be licensed by Kyowa Hakko Kogyo
Ann Oncol 1994 5: 2. [PDF] [Request Permissions]  

National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 1994 5: 2-6. [PDF] [Request Permissions]  

World Bank self-criticism on health matters
Ann Oncol 1994 5: 4. [PDF] [Request Permissions]  

Agent Orange and Seveso: No end in sight
Ann Oncol 1994 5: 4. [PDF] [Request Permissions]  

Euthanasia in Japan: Mixed feelings
Ann Oncol 1994 5: 5. [PDF] [Request Permissions]  

Corrigendum
Ann Oncol 1994 5: 5. [PDF] [Request Permissions]  

Perhaps not everyone knows that...
Ann Oncol 1994 5: 5-6. [PDF] [Request Permissions]  

Editorials Back

Franco Cavalli
A new year, a few changes
Ann Oncol 1994 5: 7. [PDF] [Request Permissions]  

G. Cocconi
Chemotherapy of advanced gastric carcinoma: To be completely rewritten?
Ann Oncol 1994 5: 8-11. [PDF] [Request Permissions]  

Special articles Back

I. G. Finlay and R. Dunlop
Quality of life assessment in palliative care
Ann Oncol 1994 5: 13-18. [PDF] [Request Permissions]  

Commentary Back

B. Coiffier, T. Philip, A. K. Burnett, and M. L Symann
Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4–6, 1993
Ann Oncol 1994 5: 19-23. [PDF] [Request Permissions]  

Arena Back

W. Sauerbrei and W. Jäger
Timing of breast cancer surgery — some arguments that there is no effect
Ann Oncol 1994 5: 25-27. [PDF] [Request Permissions]  

R. A. Badwe and R. R. Juvekar
Timing of breast cancer surgery during the menstrual cycle
Ann Oncol 1994 5: 29-31. [PDF] [Request Permissions]  

Original articles Back

R. C. Coombes, C. E. D. Chilvers, D. Amadori, F Medi, G. Fountzilas, H. Rauschecker, P. Vassilopoulos, E. Pinto Ferreira, G. Vannozzi, J. M. Bliss, E. Woods, and J. Wils
Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer: An International Collaborative Cancer Group (ICCG) study
Ann Oncol 1994 5: 33-36. [Abstract] [PDF] [Request Permissions]  

A. Depierre, Cl. Chastang, E. Quoix, B. Lebeau, F. Blachon, N. Paillot, E. Lemarie, B. Milleron, D. Moro, J. Clavier, D. Herman, E Tuchais, P. Jacoulet, J. M Brechot, J. F. Cordier, p. Solal-Celigny, N. Badri, and M. Besenval
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
Ann Oncol 1994 5: 37-42. [Abstract] [PDF] [Request Permissions]  

C. K. Osborne, M.C Sunderland, J.A. Neidhart, P.M. Ravdin, and M.D. Abeloff
Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer
Ann Oncol 1994 5: 43-47. [Abstract] [PDF] [Request Permissions]  

H. Koppler, K.-H. Pfluger, I. Eschenbach, R. Pfab, J. Birkmann, W. Zeller, R. Holle, U. E. Steinhauer, C. Gropp, S. Oehl, K. Lennert, M. R. Parwaresch, H. Kuhn, P. Drings, H. H. Gossmann, M. Khoury, R. Schubotz, and K. Havemann
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
Ann Oncol 1994 5: 49-55. [Abstract] [PDF] [Request Permissions]  

D. C. Betticher, M. F Fey, A. von Rohr, A. Tobler, H. Jenzer, A. Gratwohl, A. Lohri, P. Pugin, U. Hess, O. Pagani, G. Zulian, and T. Cerny
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias
Ann Oncol 1994 5: 57-64. [Abstract] [PDF] [Request Permissions]  

C. Huirny, J. Bernhard, A. Coates, M. Castiglione, H. F Peterson, R. D. Gelber, C.-M. Rudenstam, A. Goldhirsch, and H.-J. Senn
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimation
Ann Oncol 1994 5: 65-74. [Abstract] [PDF] [Request Permissions]  

A. G. J. van der Zee, E. G. E. de Vries, H. Hollema, S. B. Kaye, R. Brown, and W N. Keith
Molecular analysis of the topoisomerase II {alpha} gene and its expression in human ovarian cancer
Ann Oncol 1994 5: 75-81. [Abstract] [PDF] [Request Permissions]  

Book reviews Back

Book review
Ann Oncol 1994 5: 42. [PDF] [Request Permissions]  

Martin F. Fey
Book review
Ann Oncol 1994 5: 74. [PDF] [Request Permissions]  

S. Leyvraz
Book review
Ann Oncol 1994 5: 89. [PDF] [Request Permissions]  

Clinical case Back

I. Besznyák and S. Eckhardt
Male breast cancer
Ann Oncol 1994 5: 83-85. [PDF] [Request Permissions]  

Short reports Back

E. Au and P.-T. Ang
A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma
Ann Oncol 1994 5: 87-89. [Abstract] [PDF] [Request Permissions]  

B. G. Taal, F G. M. Teller, W. W. ten Bokkel Huinink, H. Boot, J.H. Beijnen, and R. Dubbelman
Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: Experience with two treatment schedules incorporating intravenous or oral etoposide
Ann Oncol 1994 5: 90-92. [Abstract] [PDF] [Request Permissions]  

G. Bisagni, G. Cocconi, Di Blasio, G. Ceci, V. De Lisi, C. Finardi, R. Lottici, and R Passalacqua
M-VAC combination in locally advanced, locally recurrent or metastatic breast carcinoma. A phase II study
Ann Oncol 1994 5: 93-94. [Abstract] [PDF] [Request Permissions]  

G. Catimel, F Chauvin, J. P. Guastalla, P. Rebattu, P. Biron, and M. Clavelt
FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy
Ann Oncol 1994 5: 95-97. [Abstract] [PDF] [Request Permissions]  

Letters Back

A. M. Childs, A. S. Coates, K. M. Cox, and P. N. Mainwaring
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron
Ann Oncol 1994 5: 98. [PDF] [Request Permissions]  

N. A. Dobbs and C.J. Twelves
Comments on epirubicin
Ann Oncol 1994 5: 98-99. [PDF] [Request Permissions]  

L. Gianni and G. bonadonna
The above letter was referred to the authors who respond as follows:
Ann Oncol 1994 5: 99. [PDF] [Request Permissions]  

Advertisements in this issue Back

Advertisements in this issue
Ann Oncol 1994 5: 100-104. [PDF] [Request Permissions]  

Instructions to Authors Back

Instruction to authors
Ann Oncol 1994 5: 101-102. [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.